Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01368588
Other study ID # RTOG-0924
Secondary ID CDR0000701128NCI
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date July 2011
Est. completion date July 2031

Study information

Verified date August 2023
Source Radiation Therapy Oncology Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.


Description:

OBJECTIVES: Primary - Demonstrate that prophylactic, neoadjuvant, androgen-deprivation therapy (NADT) and whole-pelvic radiation therapy (WPRT) will result in improvement in overall survival (OS) of patients with "unfavorable" intermediate-risk or "favorable" high-risk prostate cancer compared to NADT and high-dose prostate (P) and seminal vesicle (SV) radiation therapy (RT) using intensity-modulated RT (IMRT) or external-beam RT (EBRT) with a high-dose rate (HDR) or a permanent prostate (radioactive seed) implant (PPI) boost. Secondary - Demonstrate that prophylactic WPRT improves biochemical control. - Determine the distant metastasis (DM)-free survival. - Determine the cause-specific survival (CSS). - Compare acute and late treatment-adverse events between patients receiving NADT and WPRT versus NADT, P, and SV RT. - Determine whether health-related quality of life (HRQOL), as measured by the Expanded Prostate Cancer Index Composite (EPIC), significantly worsens with increasing aggressiveness of treatment (i.e., Arm 2, NADT + WPRT). - Determine whether more aggressive treatment (Arm 2, NADT + WPRT) is associated with a greater increase in fatigue (PROMIS Fatigue Short Form) from baseline to last week of treatment, and a greater increase in circulating inflammatory markers (IL-1, IL-1ra, IL-6, tumor necrosis factor (TNF)-alpha, and C-reactive protein). - Demonstrate an incremental gain in OS and CSS with more aggressive therapy that outweighs any detriments in the primary generic domains of HRQOL (i.e., mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). - Determine whether changes in fatigue from baseline to the next three time points (week prior to RT, last week of treatment, and 3 months after treatment) are associated with changes in circulating cytokines, mood, sleep, and daily activities across the same time points. - Collect paraffin-embedded tissue blocks, plasma, whole blood, and urine for planned and future translational research analyses. OUTLINE: This is a multicenter study. Patients are stratified according to moderate- to high-risk groups as listed in the Disease Characteristics of this abstract, type of radiotherapy boost (IMRT vs brachytherapy [Low-dose rate (LDR) using PPI or HDR]), and duration of androgen-deprivation therapy (short-term [6 months] vs long-term [32 months]). Patients are randomized to 1 of 2 treatment arms. All patients receive neoadjuvant androgen-deprivation therapy comprising bicalutamide orally (PO) once daily or flutamide PO thrice daily for 6 months, and luteinizing hormone-releasing hormone (LHRH) agonist/antagonist therapy comprising leuprolide acetate, goserelin acetate, buserelin, triptorelin, or degarelix subcutaneously (SC) or intramuscularly (IM) every 1 to 3 months beginning 2 months prior to radiotherapy and continuing for 6 or 32 months. Radiotherapy begins within 8 weeks after beginning LHRH agonist/antagonist injection. - Arm I: Patients undergo high-dose radiotherapy of the prostate and seminal vesicles using intensity-modulated radiotherapy (IMRT)* or 3D-conformal radiation therapy (3D-CRT)* once daily, 5 days a week, for approximately 9 weeks. Patients may also undergo permanent prostate implant (PPI) brachytherapy or high-dose rate brachytherapy (iodine I 125 or palladium Pd 103 may be used as the radioisotope). - Arm II: Patients undergo whole-pelvic radiotherapy (WPRT)* (3D-CRT or IMRT) once daily, 5 days a week, for approximately 9 weeks. Patients may also undergo brachytherapy as in arm I. NOTE: * Patients undergoing brachytherapy implant receive 5 weeks of IMRT, 3D-CRT, or WPRT. Patients may undergo blood and urine sample collection for correlative studies. Primary tumor tissue samples may also be collected. Patients may complete the Expanded Prostate Cancer Index Composite (EPIC), the PROMIS-Fatigue Short Form, and the EuroQol (EQ-5D) quality-of-life (QOL) questionnaires at baseline and periodically during treatment. Patients who participate in the QOL portion of the study must also agree to periodic blood collection. After completion of study therapy, patients are followed up every 3 months for 1 year, every 6 months for 3 years, and then yearly thereafter.


Other known NCT identifiers
  • NCT02673190

Recruitment information / eligibility

Status Active, not recruiting
Enrollment 2592
Est. completion date July 2031
Est. primary completion date July 2027
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS: - Pathologically (histologically or cytologically) proven diagnosis of prostatic adenocarcinoma within 180 days of registration at moderate- to high-risk for recurrence as determined by one of the following combinations: - Gleason score 7-10 + T1c-T2b (palpation) + prostate-specific antigen (PSA) < 50 ng/mL (includes intermediate- and high-risk patients) - Gleason score 6 + T2c-T4 (palpation) + PSA < 50 ng/mL OR - Gleason score 6 + >= 50% (positive) biopsies + PSA < 50 ng/ml - Gleason score 6 + T1c-T2b (palpation) + PSA > 20 ng/mL Patients previously diagnosed with low risk prostate cancer undergoing active surveillance who are re-biopsied and found to have unfavorable intermediate risk disease or favorable high risk disease according to the protocol criteria are eligible for enrollment within 180 days of the repeat biopsy procedure. - History and/or physical examination (to include at a minimum digital rectal examination of the prostate and examination of the skeletal system and abdomen) within 90 days prior to registration - Clinically negative lymph nodes as established by imaging (pelvic and/or abdominal CT or MR), (but not by nodal sampling, or dissection) within 90 days prior to registration - Patients with lymph nodes equivocal or questionable by imaging are eligible if the nodes are = 1.5 cm - Patients status post a negative lymph node dissection are not eligible - No evidence of bone metastases (M0) on bone scan within 120 days prior to registration (Na F PET/CT is an acceptable substitute) - Equivocal bone scan findings are allowed if plain films (or CT or MRI) are negative for metastasis - Baseline serum PSA value performed with an FDA-approved assay (e.g., Abbott, Hybritech) within 120 days prior to registration - Study entry PSA should not be obtained during the following time frames: - Ten-day period following prostate biopsy - Following initiation of hormonal therapy - Within 30 days after discontinuation of finasteride - Within 90 days after discontinuation of dutasteride PATIENT CHARACTERISTICS: - Zubrod performance status 0-1 - Absolute neutrophil count (ANC) = 1,500/mm³ - Platelet count = 100,000/mm³ - Hemoglobin (Hgb) = 8.0 g/dL (transfusion or other intervention to achieve Hgb = 8.0 g/dL is acceptable) - No prior invasive (except non-melanoma skin cancer) malignancy unless disease-free for a minimum of 3 years (1,095 days) and not in the pelvis - E.g., carcinoma in situ of the oral cavity is permissible; however, patients with prior history of bladder cancer are not allowed - No prior hematological (e.g., leukemia, lymphoma, or myeloma) malignancy - No previous radical surgery (prostatectomy) or cryosurgery for prostate cancer - No previous pelvic irradiation, prostate brachytherapy or bilateral orchiectomy - No previous hormonal therapy, such as LHRH agonists (e.g., leuprolide, goserelin, buserelin, triptorelin) or LHRH antagonist (e.g. degarelix), anti-androgens (e.g., flutamide, bicalutamide, cyproterone acetate), estrogens (e.g., DES), or surgical castration (orchiectomy) - Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation (both LHRH agonist and oral anti-androgen) is = 45 days prior to the date of registration. - No severe, active co-morbidity, defined as any of the following: - Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months - Transmural myocardial infarction within the last 6 months - Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration - Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration - Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects or severe liver dysfunction - Acquired immune deficiency syndrome (AIDS) based upon current Centers for Disease Control (CDC) definition - Protocol-specific requirements may also exclude immuno-compromised patients - HIV testing is not required for entry into this protocol - No patients who are sexually active and not willing/able to use medically acceptable forms of contraception - No prior allergic reaction to the hormones involved in this protocol PRIOR CONCURRENT THERAPY: - See Disease Characteristics - No prior radical surgery (prostatectomy) or cryosurgery for prostate cancer - No prior pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy - No prior hormonal therapy, such as luteinizing hormone-releasing hormone (LHRH) agonists (e.g., leuprolide, goserelin, buserelin, triptorelin) or LHRH antagonist (e.g., degarelix), anti-androgens (e.g., flutamide, bicalutamide, cyproterone acetate), estrogens (e.g., diethylstilbestrol (DES) ), or surgical castration (orchiectomy) - No prior pharmacologic androgen ablation for prostate cancer unless the onset of androgen ablation is = 45 days prior to the date of registration - No finasteride within 30 days prior to registration - No dutasteride or dutasteride/tamsulosin (Jalyn) within 90 days prior to registration - No prior or concurrent cytotoxic chemotherapy for prostate cancer - Prior chemotherapy for a different cancer is allowable - No prior radiotherapy, including brachytherapy, to the region of the study cancer that would result in overlap of radiation therapy fields

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
radiation therapy
Undergo RT using IMRT or 3D-CRT
Whole-pelvic radiotherapy (WPRT)
Undergo whole-pelvic radiotherapy (WPRT)

Locations

Country Name City State
Canada Tom Baker Cancer Centre Calgary Alberta
Canada Cross Cancer Institute Edmonton Alberta
Canada QEII Health Sciences Centre/Nova Scotia Health Authority Halifax Nova Scotia
Canada BCCA-Cancer Centre for the Southern Interior Kelowna British Columbia
Canada London Regional Cancer Program London Ontario
Canada CHUM - Centre Hospitalier de l'Universite de Montreal Montreal Quebec
Canada CHUM - Hopital Notre-Dame Montreal Quebec
Canada Jewish General Hospital Montreal Quebec
Canada McGill University Department of Oncology Montreal Quebec
Canada The Research Institute of the McGill University Health Centre (MUHC) Montreal Quebec
Canada Stronach Regional Health Centre at Southlake Newmarket Ontario
Canada CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ) Quebec City Quebec
Canada Allan Blair Cancer Centre Regina Saskatchewan
Canada Saskatoon Cancer Centre Saskatoon Saskatchewan
Canada Centre Hospitalier Universitaire de Sherbrooke-Fleurimont Sherbrooke Quebec
Canada Doctor H. Bliss Murphy Cancer Centre St. John's Newfoundland and Labrador
Canada BCCA-Fraser Valley Cancer Centre Surrey British Columbia
Canada Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto Ontario
Hong Kong Pamela Youde Nethersole Eastern Hospital Chai Wan
Israel Rabin Medical Center Petach Tikva
Israel Chaim Sheba Medical Center Tel Hashomer
Singapore National Cancer Centre Singapore Singapore
Singapore National University Hospital Singapore Singapore
Switzerland Kantonsspital Aarau Aarau
United States The Cancer Center of Hawaii-Pali Momi 'Aiea Hawaii
United States Texas Cancer Center Abilene Texas
United States Jefferson Abington Hospital Abington Pennsylvania
United States Bixby Medical Center Adrian Michigan
United States Cleveland Clinic Akron General Akron Ohio
United States Summa Health System - Akron Campus Akron Ohio
United States Mayo Clinic Health System in Albert Lea Albert Lea Minnesota
United States Lehigh Valley Hospital-Cedar Crest Allentown Pennsylvania
United States American Fork Hospital / Huntsman Intermountain Cancer Center American Fork Utah
United States McFarland Clinic PC - Ames Ames Iowa
United States Alaska Oncology and Hematology LLC Anchorage Alaska
United States Anchorage Associates in Radiation Medicine Anchorage Alaska
United States Anchorage Oncology Centre Anchorage Alaska
United States Katmai Oncology Group Anchorage Alaska
United States Providence Alaska Medical Center Anchorage Alaska
United States AnMed Health Cancer Center Anderson South Carolina
United States Saint Joseph Mercy Hospital Ann Arbor Michigan
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Veteran's Administration Medical Center - Ann Arbor Ann Arbor Michigan
United States Anne Arundel Medical Center Annapolis Maryland
United States Langlade Hospital and Cancer Center Antigo Wisconsin
United States ThedaCare Regional Cancer Center Appleton Wisconsin
United States ThedaCare Regional Medical Center - Appleton Appleton Wisconsin
United States Northwest Community Hospital Arlington Heights Illinois
United States Emory Saint Joseph's Hospital Atlanta Georgia
United States Emory University Hospital Midtown Atlanta Georgia
United States Emory University Hospital/Winship Cancer Institute Atlanta Georgia
United States Grady Health System Atlanta Georgia
United States Piedmont Hospital Atlanta Georgia
United States Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn California
United States Rocky Mountain Cancer Centers-Aurora Aurora Colorado
United States Rush - Copley Medical Center Aurora Illinois
United States University of Colorado Hospital Aurora Colorado
United States AIS Cancer Center at San Joaquin Community Hospital Bakersfield California
United States Greater Baltimore Medical Center Baltimore Maryland
United States Saint Agnes Hospital Baltimore Maryland
United States University of Maryland/Greenebaum Cancer Center Baltimore Maryland
United States Summa Health System - Barberton Campus Barberton Ohio
United States Mary Bird Perkins Cancer Center Baton Rouge Louisiana
United States Bronson Battle Creek Battle Creek Michigan
United States McLaren Cancer Institute-Bay City Bay City Michigan
United States South Shore University Hospital Bay Shore New York
United States UHHS-Chagrin Highlands Medical Center Beachwood Ohio
United States Texas Oncology PA Beaumont Beaumont Texas
United States UM Upper Chesapeake Medical Center Bel Air Maryland
United States Sanford Joe Lueken Cancer Center Bemidji Minnesota
United States Southwestern Vermont Medical Center Bennington Vermont
United States Alta Bates Summit Medical Center-Herrick Campus Berkeley California
United States Central Vermont Medical Center/National Life Cancer Treatment Berlin Vermont
United States Billings Clinic Cancer Center Billings Montana
United States Prisma Health Cancer Institute - Spartanburg Boiling Springs South Carolina
United States Saint Alphonsus Cancer Care Center-Boise Boise Idaho
United States Massachusetts General Hospital Cancer Center Boston Massachusetts
United States Rocky Mountain Cancer Centers-Boulder Boulder Colorado
United States Hartford HealthCare - Saint Vincent's Medical Center Bridgeport Connecticut
United States United Hospital Center Bridgeport West Virginia
United States James J Peters VA Medical Center Bronx New York
United States Ascension Southeast Wisconsin Hospital - Elmbrook Campus Brookfield Wisconsin
United States New York-Presbyterian/Brooklyn Methodist Hospital Brooklyn New York
United States Henry Ford Cancer Institute-Downriver Brownstown Michigan
United States Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank California
United States University of Vermont Medical Center Burlington Vermont
United States Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park California
United States Sands Cancer Center Canandaigua New York
United States Cleveland Clinic Mercy Hospital Canton Ohio
United States Saint Francis Medical Center Cape Girardeau Missouri
United States Southeast Cancer Center Cape Girardeau Missouri
United States Mercy San Juan Medical Center Carmichael California
United States Sandra L Maxwell Cancer Center Cedar City Utah
United States Mercy Hospital Cedar Rapids Iowa
United States Saint Luke's Hospital Cedar Rapids Iowa
United States UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina
United States Geauga Hospital Chardon Ohio
United States Medical University of South Carolina Charleston South Carolina
United States University of Virginia Cancer Center Charlottesville Virginia
United States Erlanger Medical Center Chattanooga Tennessee
United States Advocate Illinois Masonic Medical Center Chicago Illinois
United States John H Stroger Jr Hospital of Cook County Chicago Illinois
United States Rush University Medical Center Chicago Illinois
United States UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital Chicago Illinois
United States Weiss Memorial Hospital Chicago Illinois
United States Adventist Health Cancer Care Center Chico Chico California
United States Adena Regional Medical Center Chillicothe Ohio
United States Clackamas Radiation Oncology Center Clackamas Oregon
United States GenesisCare USA - Clarkston Clarkston Michigan
United States McLaren Cancer Institute-Clarkston Clarkston Michigan
United States Case Western Reserve University Cleveland Ohio
United States Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio
United States Cleveland Clinic Foundation Cleveland Ohio
United States Henry Ford Macomb Hospital-Clinton Township Clinton Township Michigan
United States Billings Clinic-Cody Cody Wyoming
United States Kootenai Health - Coeur d'Alene Coeur d'Alene Idaho
United States UCHealth Memorial Hospital Central Colorado Springs Colorado
United States Central Maryland Radiation Oncology in Howard County Columbia Maryland
United States John B Amos Cancer Center Columbus Georgia
United States Mount Carmel Health Center West Columbus Ohio
United States Ohio State University Comprehensive Cancer Center Columbus Ohio
United States The Mark H Zangmeister Center Columbus Ohio
United States Mary Imogene Bassett Hospital Cooperstown New York
United States Mary Bird Perkins Cancer Center - Covington Covington Louisiana
United States Siteman Cancer Center at West County Hospital Creve Coeur Missouri
United States UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas
United States Geisinger Medical Center Danville Pennsylvania
United States Beaumont Hospital - Dearborn Dearborn Michigan
United States Atlanta VA Medical Center Decatur Georgia
United States Decatur Memorial Hospital Decatur Illinois
United States Broward Health North Deerfield Beach Florida
United States Texas Oncology - Denison Cancer Center Denison Texas
United States Porter Adventist Hospital Denver Colorado
United States Ascension Saint John Hospital Detroit Michigan
United States Henry Ford Hospital Detroit Michigan
United States Wayne State University/Karmanos Cancer Institute Detroit Michigan
United States Finley Hospital Dubuque Iowa
United States Saint Luke's Hospital of Duluth Duluth Minnesota
United States Northeast Radiation Oncology Center Dunmore Pennsylvania
United States Duke University Medical Center Durham North Carolina
United States Durham VA Medical Center Durham North Carolina
United States Marshfield Medical Center-EC Cancer Center Eau Claire Wisconsin
United States Mayo Clinic Health System Eau Claire Hospital-Luther Campus Eau Claire Wisconsin
United States Shaw Cancer Center Edwards Colorado
United States Crossroads Cancer Center Effingham Illinois
United States AtlantiCare Surgery Center Egg Harbor Township New Jersey
United States University of Maryland Radiation Oncology Center at Union Hospital Elkton Maryland
United States Arnot Ogden Medical Center/Falck Cancer Center Elmira New York
United States Mercy Cancer Center-Elyria Elyria Ohio
United States Ephrata Cancer Center Ephrata Pennsylvania
United States Exeter Hospital Exeter New Hampshire
United States Fairbanks Memorial Hospital Fairbanks Alaska
United States Saint Anne's Hospital Fall River Massachusetts
United States Sanford Broadway Medical Center Fargo North Dakota
United States Beaumont Hospital - Farmington Hills Farmington Hills Michigan
United States GenesisCare USA - Farmington Hills Farmington Hills Michigan
United States Weisberg Cancer Treatment Center Farmington Hills Michigan
United States Piedmont Fayette Hospital Fayetteville Georgia
United States Saint Francis Hospital Federal Way Washington
United States Augusta Health Center for Cancer and Blood Disorders Fishersville Virginia
United States McLaren Cancer Institute-Flint Flint Michigan
United States Brooke Army Medical Center Fort Sam Houston Texas
United States Parkview Hospital Randallia Fort Wayne Indiana
United States Parkview Regional Medical Center Fort Wayne Indiana
United States Radiation Oncology Associates PC Fort Wayne Indiana
United States Texas Oncology - Fort Worth Cancer Center Fort Worth Texas
United States Ascension Saint Francis - Reiman Cancer Center Franklin Wisconsin
United States Fresno Cancer Center Fresno California
United States Saint Agnes Medical Center Fresno California
United States Fox Chase Cancer Center Buckingham Furlong Pennsylvania
United States Northeast Georgia Medical Center-Gainesville Gainesville Georgia
United States University of Texas Medical Branch Galveston Texas
United States Central Care Cancer Center - Garden City Garden City Kansas
United States Saint Catherine Hospital Garden City Kansas
United States Tidelands Georgetown Memorial Hospital Georgetown South Carolina
United States Adams Cancer Center Gettysburg Pennsylvania
United States Arizona Breast Cancer Specialists-Gilbert Gilbert Arizona
United States UM Baltimore Washington Medical Center/Tate Cancer Center Glen Burnie Maryland
United States Mercy Health Saint Mary's Grand Rapids Michigan
United States Spectrum Health at Butterworth Campus Grand Rapids Michigan
United States Three Rivers Community Hospital Grants Pass Oregon
United States Benefis Healthcare- Sletten Cancer Institute Great Falls Montana
United States North Colorado Medical Center Greeley Colorado
United States Aurora BayCare Medical Center Green Bay Wisconsin
United States Saint Vincent Hospital Cancer Center at Saint Mary's Green Bay Wisconsin
United States Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin
United States Marin General Hospital Greenbrae California
United States Prisma Health Cancer Institute - Eastside Greenville South Carolina
United States Prisma Health Cancer Institute - Faris Greenville South Carolina
United States Saint Francis Cancer Center Greenville South Carolina
United States Self Regional Healthcare Greenwood South Carolina
United States Gibbs Cancer Center-Pelham Greer South Carolina
United States Prisma Health Cancer Institute - Greer Greer South Carolina
United States Sentara Cancer Institute at Sentara CarePlex Hospital Hampton Virginia
United States Cherry Tree Cancer Center Hanover Pennsylvania
United States Sentara Rockingham Memorial Hospital Hahn Cancer Center Harrisonburg Virginia
United States Smilow Cancer Hospital Care Center at Saint Francis Hartford Connecticut
United States Penn State Milton S Hershey Medical Center Hershey Pennsylvania
United States The Radiation Oncology Center-Hilton Head/Bluffton Hilton Head Island South Carolina
United States Queen's Medical Center Honolulu Hawaii
United States The Cancer Center of Hawaii-Liliha Honolulu Hawaii
United States CHI Saint Vincent Cancer Center Hot Springs Hot Springs Arkansas
United States Mary Bird Perkins Cancer Center - Houma Houma Louisiana
United States Ben Taub General Hospital Houston Texas
United States Memorial Hermann Memorial City Medical Center Houston Texas
United States Cape Cod Hospital Hyannis Massachusetts
United States Cleveland Clinic Cancer Center Independence Independence Ohio
United States Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana
United States IU Health Methodist Hospital Indianapolis Indiana
United States University of Mississippi Medical Center Jackson Mississippi
United States Baptist MD Anderson Cancer Center Jacksonville Florida
United States Baptist Medical Center South Jacksonville Florida
United States UW Cancer Center Johnson Creek Johnson Creek Wisconsin
United States Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro Arkansas
United States Freeman Health System Joplin Missouri
United States Jupiter Medical Center Jupiter Florida
United States West Michigan Cancer Center Kalamazoo Michigan
United States Kansas City Veterans Affairs Medical Center Kansas City Missouri
United States North Kansas City Hospital Kansas City Missouri
United States The University of Kansas Cancer Center-South Kansas City Missouri
United States University of Kansas Cancer Center Kansas City Kansas
United States University of Kansas Cancer Center - North Kansas City Missouri
United States Wellmont Holston Valley Hospital and Medical Center Kingsport Tennessee
United States Gundersen Lutheran Medical Center La Crosse Wisconsin
United States Mayo Clinic Health System-Franciscan Healthcare La Crosse Wisconsin
United States UC San Diego Moores Cancer Center La Jolla California
United States Northwell Health/Center for Advanced Medicine Lake Success New York
United States Karmanos Cancer Institute at McLaren Greater Lansing Lansing Michigan
United States Sparrow Hospital Lansing Michigan
United States McLaren Cancer Institute-Lapeer Region Lapeer Michigan
United States Memorial Medical Center - Las Cruces Las Cruces New Mexico
United States Lawrence Memorial Hospital Lawrence Kansas
United States UTMB Cancer Center at Victory Lakes League City Texas
United States Dartmouth Hitchcock Medical Center Lebanon New Hampshire
United States Sechler Family Cancer Center Lebanon Pennsylvania
United States University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri
United States University of Kentucky/Markey Cancer Center Lexington Kentucky
United States University of Arkansas for Medical Sciences Little Rock Arkansas
United States Saint Mary Mercy Hospital Livonia Michigan
United States Tibor Rubin VA Medical Center Long Beach California
United States Longmont United Hospital Longmont Colorado
United States Cedars Sinai Medical Center Los Angeles California
United States Los Angeles County-USC Medical Center Los Angeles California
United States USC / Norris Comprehensive Cancer Center Los Angeles California
United States McKee Medical Center Loveland Colorado
United States Lowell General Hospital Lowell Massachusetts
United States Central Georgia Gynecologic Oncology Macon Georgia
United States University of Wisconsin Hospital and Clinics Madison Wisconsin
United States Mayo Clinic Health Systems-Mankato Mankato Minnesota
United States Cleveland Clinic Cancer Center Mansfield Mansfield Ohio
United States Aurora Bay Area Medical Group-Marinette Marinette Wisconsin
United States Bay Area Medical Center Marinette Wisconsin
United States Marshfield Medical Center-Marshfield Marshfield Wisconsin
United States Fremont - Rideout Cancer Center Marysville California
United States Toledo Clinic Cancer Centers-Maumee Maumee Ohio
United States Hillcrest Hospital Cancer Center Mayfield Heights Ohio
United States Loyola University Medical Center Maywood Illinois
United States Texas Oncology-McAllen McAllen Texas
United States Texas Oncology-McKinney McKinney Texas
United States Providence Medford Medical Center Medford Oregon
United States Rogue Valley Medical Center Medford Oregon
United States Summa Health Medina Medical Center Medina Ohio
United States Froedtert Menomonee Falls Hospital Menomonee Falls Wisconsin
United States UH Seidman Cancer Center at Lake Health Mentor Campus Mentor Ohio
United States Ascension Columbia Saint Mary's Hospital Ozaukee Mequon Wisconsin
United States Mercy UC Davis Cancer Center Merced California
United States Idaho Urologic Institute-Meridian Meridian Idaho
United States East Jefferson General Hospital Metairie Louisiana
United States LSU Healthcare Network / Metairie Multi-Specialty Clinic Metairie Louisiana
United States University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida
United States UH Seidman Cancer Center at Southwest General Hospital Middleburg Heights Ohio
United States Middlesex Hospital Middletown Connecticut
United States Upper Delaware Valley Cancer Center Milford Pennsylvania
United States Ascension Columbia Saint Mary's Hospital - Milwaukee Milwaukee Wisconsin
United States Ascension Southeast Wisconsin Hospital - Saint Joseph Campus Milwaukee Wisconsin
United States Aurora Saint Luke's Medical Center Milwaukee Wisconsin
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Zablocki Veterans Administration Medical Center Milwaukee Wisconsin
United States Hennepin County Medical Center Minneapolis Minnesota
United States Marshfield Clinic-Minocqua Center Minocqua Wisconsin
United States University of South Alabama Mitchell Cancer Institute Mobile Alabama
United States Memorial Medical Center Modesto California
United States Monticello Cancer Center Monticello Minnesota
United States The Coleman Radiation Center-Carteret General Hospital Morehead City North Carolina
United States West Virginia University Healthcare Morgantown West Virginia
United States McLaren Cancer Institute-Macomb Mount Clemens Michigan
United States Virtua Memorial Mount Holly New Jersey
United States McLaren Cancer Institute-Central Michigan Mount Pleasant Michigan
United States Inspira Medical Center Mullica Hill Mullica Hill New Jersey
United States Intermountain Medical Center Murray Utah
United States Mercy Health Mercy Campus Muskegon Michigan
United States Vanderbilt University/Ingram Cancer Center Nashville Tennessee
United States Long Island Jewish Medical Center New Hyde Park New York
United States Ochsner Medical Center Jefferson New Orleans Louisiana
United States Touro Infirmary New Orleans Louisiana
United States Tulane University Health Sciences Center New Orleans Louisiana
United States NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York
United States Christiana Care Health System-Christiana Hospital Newark Delaware
United States Helen F Graham Cancer Center Newark Delaware
United States Bon Secours DePaul Medical Center Norfolk Virginia
United States Sentara Norfolk General Hospital Norfolk Virginia
United States Alta Bates Summit Medical Center - Summit Campus Oakland California
United States Kaiser Permanente Oakland-Broadway Oakland California
United States West Texas Cancer Center Odessa Texas
United States McKay-Dee Hospital Center Ogden Utah
United States Ogden Regional Medical Center Ogden Utah
United States University of Oklahoma Health Sciences Center Oklahoma City Oklahoma
United States Olathe Health Cancer Center Olathe Kansas
United States Alegent Health Bergan Mercy Medical Center Omaha Nebraska
United States University of Nebraska Medical Center Omaha Nebraska
United States Saint Charles Hospital Oregon Ohio
United States Orlando Health Cancer Institute Orlando Florida
United States Vince Lombardi Cancer Clinic - Oshkosh Oshkosh Wisconsin
United States University of Kansas Cancer Center-Overland Park Overland Park Kansas
United States Owensboro Health Mitchell Memorial Cancer Center Owensboro Kentucky
United States McLaren Cancer Institute-Owosso Owosso Michigan
United States Cancer Center of Putnam Palatka Florida
United States Desert Regional Medical Center Palm Springs California
United States Palo Alto Medical Foundation Health Care Palo Alto California
United States Stanford Cancer Institute Palo Alto Palo Alto California
United States Parker Adventist Hospital Parker Colorado
United States University Hospitals Parma Medical Center Parma Ohio
United States Singing River Hospital Pascagoula Mississippi
United States Arizona Center for Cancer Care-Peoria Peoria Arizona
United States OSF Saint Francis Medical Center Peoria Illinois
United States OSF Saint Francis Radiation Oncology at Peoria Cancer Center Peoria Illinois
United States McLaren Cancer Institute-Northern Michigan Petoskey Michigan
United States Fox Chase Cancer Center Philadelphia Pennsylvania
United States Arizona Breast Cancer Specialists-Phoenix Phoenix Arizona
United States Arizona Oncology-Deer Valley Center Phoenix Arizona
United States Cancer Center at Saint Joseph's Phoenix Arizona
United States Saint Joseph's Hospital and Medical Center Phoenix Arizona
United States FirstHealth of the Carolinas-Moore Regional Hospital Pinehurst North Carolina
United States VA Pittsburgh Healthcare System Pittsburgh Pennsylvania
United States Penn Medicine Princeton Health Plainsboro New Jersey
United States Texas Oncology-Plano West Plano Texas
United States GenesisCare USA - Plantation Plantation Florida
United States Beth Israel Deaconess Hospital-Plymouth Plymouth Massachusetts
United States Pomona Valley Hospital Medical Center Pomona California
United States 21st Century Oncology-Pontiac Pontiac Michigan
United States Saint Joseph Mercy Oakland Pontiac Michigan
United States McLaren-Port Huron Port Huron Michigan
United States Kaiser Permanente Northwest Portland Oregon
United States Providence Portland Medical Center Portland Oregon
United States Providence Saint Vincent Medical Center Portland Oregon
United States Naval Medical Center - Portsmouth Portsmouth Virginia
United States Southern Ohio Medical Center Portsmouth Ohio
United States Kootenai Clinic Cancer Services - Post Falls Post Falls Idaho
United States Utah Valley Regional Medical Center Provo Utah
United States Ascension All Saints Hospital Racine Wisconsin
United States UNC Rex Cancer Center Raleigh North Carolina
United States Kaiser Permanente-Rancho Cordova Cancer Center Rancho Cordova California
United States University Hospitals Portage Medical Center Ravenna Ohio
United States Beebe Health Campus Rehoboth Beach Delaware
United States Renown Regional Medical Center Reno Nevada
United States Marshfield Medical Center-Rice Lake Rice Lake Wisconsin
United States Hunter Holmes McGuire Veterans Administration Medical Center Richmond Virginia
United States Oncology and Hematology Associates of Southwest Virginia Roanoke Virginia
United States Highland Hospital Rochester New York
United States University of Rochester Rochester New York
United States Wilmot Cancer Institute Radiation Oncology at Greece Rochester New York
United States SwedishAmerican Regional Cancer Center/ACT Rockford Illinois
United States Rohnert Park Cancer Center Rohnert Park California
United States Delbert Day Cancer Institute at PCRMC Rolla Missouri
United States Sutter Cancer Centers Radiation Oncology Services-Roseville Roseville California
United States The Permanente Medical Group-Roseville Radiation Oncology Roseville California
United States William Beaumont Hospital-Royal Oak Royal Oak Michigan
United States Mercy Cancer Center - Sacramento Sacramento California
United States South Sacramento Cancer Center Sacramento California
United States Sutter Medical Center Sacramento Sacramento California
United States University of California Davis Comprehensive Cancer Center Sacramento California
United States Ascension Saint Mary's Hospital Saginaw Michigan
United States Coborn Cancer Center at Saint Cloud Hospital Saint Cloud Minnesota
United States Dixie Medical Center Regional Cancer Center Saint George Utah
United States Norris Cotton Cancer Center-North Saint Johnsbury Vermont
United States Heartland Regional Medical Center Saint Joseph Missouri
United States Lakeland Medical Center Saint Joseph Saint Joseph Michigan
United States Mercy Hospital Saint Louis Saint Louis Missouri
United States Missouri Baptist Medical Center Saint Louis Missouri
United States Siteman Cancer Center-South County Saint Louis Missouri
United States Veteran's Affairs Medical Center - Saint Louis Saint Louis Missouri
United States Washington University School of Medicine Saint Louis Missouri
United States Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota
United States Regions Hospital Saint Paul Minnesota
United States Siteman Cancer Center at Saint Peters Hospital Saint Peters Missouri
United States UH Seidman Cancer Center at Salem Regional Medical Center Salem Ohio
United States TidalHealth Peninsula Regional Salisbury Maryland
United States Huntsman Cancer Institute/University of Utah Salt Lake City Utah
United States Utah Cancer Specialists-Salt Lake City Salt Lake City Utah
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States UCSF Medical Center-Mission Bay San Francisco California
United States UCSF Medical Center-Mount Zion San Francisco California
United States Santa Clara Valley Medical Center San Jose California
United States Kootenai Cancer Clinic Sandpoint Idaho
United States North Coast Cancer Care Sandusky Ohio
United States UH Seidman Cancer Center at Firelands Regional Medical Center Sandusky Ohio
United States Kaiser Permanente Medical Center - Santa Clara Santa Clara California
United States Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah Georgia
United States 21st Century Oncology-Scottsdale Scottsdale Arizona
United States Arizona Breast Cancer Specialists Scottsdale Arizona
United States Arizona Breast Cancer Specialists-Scottsdale Scottsdale Arizona
United States Arizona Oncology Services Foundation Scottsdale Arizona
United States TidalHealth Nanticoke / Allen Cancer Center Seaford Delaware
United States Virginia Mason Medical Center Seattle Washington
United States Prisma Health Cancer Institute - Seneca Seneca South Carolina
United States Sidney Kimmel Cancer Center Washington Township Sewell New Jersey
United States HSHS Saint Nicholas Hospital Sheboygan Wisconsin
United States Vince Lombardi Cancer Clinic-Sheboygan Sheboygan Wisconsin
United States Sanford USD Medical Center - Sioux Falls Sioux Falls South Dakota
United States Robert Wood Johnson University Hospital Somerset Somerville New Jersey
United States Memorial Hospital of South Bend South Bend Indiana
United States Kaiser Permanente Cancer Treatment Center South San Francisco California
United States Sparta Cancer Treatment Center Sparta New Jersey
United States Spartanburg Medical Center Spartanburg South Carolina
United States CoxHealth South Hospital Springfield Missouri
United States Memorial Medical Center Springfield Illinois
United States Saint John's Hospital Springfield Illinois
United States Marshfield Clinic Stevens Point Center Stevens Point Wisconsin
United States Saint Joseph's Medical Center Stockton California
United States Stony Brook University Medical Center Stony Brook New York
United States Cleveland Clinic Cancer Center Strongsville Strongsville Ohio
United States Saint Vincent Hospital Cancer Center at Sturgeon Bay Sturgeon Bay Wisconsin
United States Sentara Obici Hospital Suffolk Virginia
United States Texas Oncology Cancer Center Sugar Land Sugar Land Texas
United States Aurora Medical Center in Summit Summit Wisconsin
United States Palo Alto Medical Foundation-Sunnyvale Sunnyvale California
United States NHRMC Radiation Oncology - Supply Supply North Carolina
United States Arizona Center for Cancer Care-Surprise Surprise Arizona
United States Southwest Illinois Health Services LLP Swansea Illinois
United States ProMedica Flower Hospital Sylvania Ohio
United States Madigan Army Medical Center Tacoma Washington
United States James A. Haley Veterans Affairs Hospital Tampa Florida
United States Mercy Health - Saint Anne Hospital Toledo Ohio
United States University of Toledo Toledo Ohio
United States Cotton O'Neil Cancer Center / Stormont Vail Health Topeka Kansas
United States UM Saint Joseph Medical Center Towson Maryland
United States Florida Cancer Affiliates Trinity Florida
United States GenesisCare USA - Troy Troy Michigan
United States William Beaumont Hospital - Troy Troy Michigan
United States Gene Upshaw Memorial Tahoe Forest Cancer Center Truckee California
United States Arizona Oncology Associates-West Orange Grove Tucson Arizona
United States Banner University Medical Center - Tucson Tucson Arizona
United States University of Arizona Cancer Center-North Campus Tucson Arizona
United States University of Arizona Cancer Center-Orange Grove Campus Tucson Arizona
United States Saint John Medical Center Tulsa Oklahoma
United States Saint Luke's Cancer Institute - Twin Falls Twin Falls Idaho
United States Vince Lombardi Cancer Clinic-Two Rivers Two Rivers Wisconsin
United States Carle Cancer Center Urbana Illinois
United States Sutter Cancer Centers Radiation Oncology Services-Vacaville Vacaville California
United States PeaceHealth Southwest Medical Center Vancouver Washington
United States Inspira Medical Center Vineland Vineland New Jersey
United States Sentara Virginia Beach General Hospital Virginia Beach Virginia
United States Virtua Voorhees Voorhees New Jersey
United States Saint John Macomb-Oakland Hospital Warren Michigan
United States MedStar Washington Hospital Center Washington District of Columbia
United States Aspirus Regional Cancer Center Wausau Wisconsin
United States Deke Slayton Cancer Center Webster Texas
United States Aurora West Allis Medical Center West Allis Wisconsin
United States Froedtert West Bend Hospital/Kraemer Cancer Center West Bend Wisconsin
United States Henry Ford West Bloomfield Hospital West Bloomfield Michigan
United States Reading Hospital West Reading Pennsylvania
United States UHHS-Westlake Medical Center Westlake Ohio
United States Cleveland Clinic-Weston Weston Florida
United States Ascension Via Christi Hospitals Wichita Wichita Kansas
United States Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre Pennsylvania
United States Rice Memorial Hospital Willmar Minnesota
United States Asplundh Cancer Pavilion Willow Grove Pennsylvania
United States NHRMC Radiation Oncology - 16th Street Wilmington North Carolina
United States Novant Health Forsyth Medical Center Winston-Salem North Carolina
United States Wake Forest University Health Sciences Winston-Salem North Carolina
United States Aspirus Cancer Care - Wisconsin Rapids Wisconsin Rapids Wisconsin
United States Cancer Treatment Center Wooster Ohio
United States Cleveland Clinic Wooster Family Health and Surgery Center Wooster Ohio
United States Wright-Patterson Medical Center Wright-Patterson Air Force Base Ohio
United States Metro Health Hospital Wyoming Michigan
United States North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Yakima Washington
United States WellSpan Health-York Hospital York Pennsylvania
United States Genesis Healthcare System Cancer Care Center Zanesville Ohio

Sponsors (3)

Lead Sponsor Collaborator
Radiation Therapy Oncology Group National Cancer Institute (NCI), NRG Oncology

Countries where clinical trial is conducted

United States,  Canada,  Hong Kong,  Israel,  Singapore,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Survival From date of randomization to the date of death.
Secondary Cause-specific survival From date of randomization to the date of death due to prostate cancer.
Secondary Distant metastasis-free survival From date of randomization to the date of first documented distant metastasis or date of first clinical and/or radiographic appearance of disseminated disease.
Secondary Biochemical failure by the Phoenix definition (PSA = 2 ng/mL over the nadir PSA) From date of randomization to the date of first biochemical failure by phoenix definition within 5 years of randomization.
Secondary Incidence of "acute" adverse events as assessed by the Common Toxicity Criteria for Adverse Effects (CTCAE) current version From protocol treatment start date to the date of first occurrence of worst severity of the adverse event </= 30 days from completion of radiation therapy.
Secondary Time to "late" grade 3+ adverse events as assessed by CTCAE current version From protocol treatment start date to the date of the first late grade 3+ adverse event occurring more than 30 days after the completion of radiation therapy.
Secondary Prostate cancer-specific HRQOL change as measured by the EPIC-26 (bowel or urinary domain) Date when baseline EPIC-26 completed to 6 months post radiation therapy, 1 year post radiation therapy and 5 years post radiation therapy.
Secondary Fatigue status as measured by the Patient-Reported Outcome Measurement Information System (PROMIS) fatigue-domain change score From the date when the baseline PROMIS is completed to the last week of treatment.
Secondary Assessment and comparison of Quality Adjusted Life Years (QALYs) From the baseline QALYs assessment to the last week of radiation therapy (RT), 3 months post RT, 6 months post RT, 1 year post RT and 5 years post RT.
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Active, not recruiting NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A